Protective effects of GV1001 on myocardial ischemia-reperfusion injury

The potential cardioprotective effects of the novel vaccine peptide GV1001 were evaluated in myocardial ischemia-reperfusion injury induced rat models. GV1001 is a human telomerase reverse transcriptase derived peptide, which has been reported to possess both anti-tumor and anti-inflammatory effects...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Ji-Eun, Kim, Hyun Jun, Jheon, Sanghoon, Lim, Cheong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865859/
https://www.ncbi.nlm.nih.gov/pubmed/28944828
http://dx.doi.org/10.3892/mmr.2017.7528

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865859/
https://www.ncbi.nlm.nih.gov/pubmed/28944828
http://dx.doi.org/10.3892/mmr.2017.7528

Ejemplares similares